Search
Atezolizumab per al tractament del carcinoma urotelial localment avançat o metastàtic
(2018-10-18)
Urothelial carcinoma (CU) of urinary tract, also known as cell carcinoma transitional of the urinary tract, represents around 85-95% of all the cancers of the urinary tract. The term urothelial refers to the epithelium ...
Ús de recursos i despesa sanitària abans i després d’un ictus agut (10/2018)
(2018-03)
Stroke is an acute disease caused by an alteration of the blood circulation to the brain. From the year 2006 exists, in Catalonia, the stroke Code, which allows you to give a quick and adequate response to these emergencies, ...
Edoxaban: prevenció de l'ictus i de l'embòlia sistèmica en pacients adults amb fibril.lació auricular no valvular amb almenys un factor de risc
(2017-02)
Edoxaban is the third direct inhibitor of factor X marketed in Spain. In the main clinical trial, it has shown similar efficacy in the prevention of stroke or systemic embolism and a reduction in serious haemorrhages ...
Brentuximab vedotina per al tractament de la malaltia de Hodgkin: informe d'avaulació de resultats
(2018)
Lymphoma or Hodgkin's disease is a neoplasm that affects the lymphatic tissue. Symptomatology includes the growth of lymph nodes, spleen and other immune tissues, as well as fever, weight loss, fatigue, night sweats and ...